<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="italic;} CureusCureus2168-8184Cureus2168-8184CureusPalo Alto (CA) doi: 10.7759/cureus.8136 : Internal Medicine: Pathology:" exact="Infectious" post="Disease Pathological Findings and Management of COVID-19 Patients: A"/>
 <result pre="CureusCureus2168-8184Cureus2168-8184CureusPalo Alto (CA) doi: 10.7759/cureus.8136 : Internal Medicine: Pathology: Infectious" exact="Disease" post="Pathological Findings and Management of COVID-19 Patients: A Brief"/>
 <result pre="reaction (PCR; rt-PCR) is the gold standard diagnostic test, and" exact="chest" post="X-ray and computed tomography (CT) scan are the other"/>
 <result pre="English literature from the past five years, we had a" exact="total" post="of 31 papers to review. Most of the COVID-19"/>
 <result pre="to review. Most of the COVID-19 affected patients have mild" exact="pneumonia" post="symptoms, and those with severe disease have comorbidities. Patients"/>
 <result pre="affected patients have mild pneumonia symptoms, and those with severe" exact="disease" post="have comorbidities. Patients with COVID-19 had pathological findings, like"/>
 <result pre="Patients with COVID-19 had pathological findings, like ground-glass opacities, consolidations," exact="pleural" post="effusion, lymphadenopathy, and interstitial infiltration of inflammatory cells. Radiological"/>
 <result pre="Patients with mild symptoms should self-quarantine, whereas those with severe" exact="acute" post="respiratory distress syndrome (ARDS) are treated in the hospital."/>
 <result pre="with mild symptoms should self-quarantine, whereas those with severe acute" exact="respiratory" post="distress syndrome (ARDS) are treated in the hospital. Medications"/>
 <result pre="symptoms should self-quarantine, whereas those with severe acute respiratory distress" exact="syndrome" post="(ARDS) are treated in the hospital. Medications under trial"/>
 <result pre="is yet to be studied in detail. coronavirus covid-19 ards" exact="viral pneumonia" post="hydroxychloroquine pandemic corona pandemic passive immunization The content published"/>
 <result pre="yet to be studied in detail. coronavirus covid-19 ards viral" exact="pneumonia" post="hydroxychloroquine pandemic corona pandemic passive immunization The content published"/>
 <result pre="and background As of April 16 2020, there are a" exact="total" post="of 1,991,562 confirmed cases and 130,885 reported deaths due"/>
 <result pre="80 and those having comorbid conditions like hypertension, diabetes, and" exact="chronic" post="respiratory disorders [2]. Approximately 48% of the people who"/>
 <result pre="and those having comorbid conditions like hypertension, diabetes, and chronic" exact="respiratory" post="disorders [2]. Approximately 48% of the people who have"/>
 <result pre="condition, 30% were hypertensive, 19% were diabetics, and 8% had" exact="coronary heart disease" post="[3]. This virus belongs to the family of viruses"/>
 <result pre="30% were hypertensive, 19% were diabetics, and 8% had coronary" exact="heart" post="disease [3]. This virus belongs to the family of"/>
 <result pre="were hypertensive, 19% were diabetics, and 8% had coronary heart" exact="disease" post="[3]. This virus belongs to the family of viruses"/>
 <result pre="animals to humans, and among humans, the virus transmitted via" exact="respiratory" post="droplets [3,5]. The virus has very high transmissibility as"/>
 <result pre="COVID-19 in susceptible patients causes pneumonia, which rapidly progresses to" exact="acute" post="respiratory distress syndrome (ARDS).Â The exact pathogenesis is currently"/>
 <result pre="in susceptible patients causes pneumonia, which rapidly progresses to acute" exact="respiratory" post="distress syndrome (ARDS).Â The exact pathogenesis is currently unknown;"/>
 <result pre="patients causes pneumonia, which rapidly progresses to acute respiratory distress" exact="syndrome" post="(ARDS).Â The exact pathogenesis is currently unknown; however, it"/>
 <result pre="specific cytotoxic lymphocytes that destroy the infected cells [4]. On" exact="chest" post="X-ray and chest computed tomography (CT), ground-glass opacities, patchy"/>
 <result pre="that destroy the infected cells [4]. On chest X-ray and" exact="chest" post="computed tomography (CT), ground-glass opacities, patchy consolidation, and interstitial"/>
 <result pre="oxygen, and mechanical ventilation is provided to patients in severe" exact="respiratory" post="distress [2]. Two drugs, remdesevir and chloroquine, have shown"/>
 <result pre="is too soon to state their efficacy as there is" exact="limited" post="data on the effectiveness of these drugs in COVID-19"/>
 <result pre="some good results [8]. As we know, currently, there is" exact="limited" post="knowledge available on the pathophysiology and treatment options for"/>
 <result pre="affected patients. We used Pubmed and Google Scholar as our" exact="primary" post="database research engines to find the relevant data. Keywords"/>
 <result pre="passive immunization yielded 287 results. Out of these results, a" exact="total" post="of forty articles relevant to our topic were selected."/>
 <result pre="that a combination of lopinavir/Ritonavir combination was effective in decreasing" exact="viral" post="load. Five studies argued that convalescent plasma showed promising"/>
 <result pre="1 Some of the studies included in the review ARDS," exact="acute" post="respiratory distress syndrome [9-13] Author, Year of study Type"/>
 <result pre="Some of the studies included in the review ARDS, acute" exact="respiratory" post="distress syndrome [9-13] Author, Year of study Type of"/>
 <result pre="the studies included in the review ARDS, acute respiratory distress" exact="syndrome" post="[9-13] Author, Year of study Type of the study"/>
 <result pre="Conclusion Li T (2020) Recommendation To give comprehensive recommendations about" exact="Severe" post="Acute Respiratory Syndrome Corona-virus 2 (COVID-19). Â A combination"/>
 <result pre="Li T (2020) Recommendation To give comprehensive recommendations about Severe" exact="Acute" post="Respiratory Syndrome Corona-virus 2 (COVID-19). Â A combination of"/>
 <result pre="T (2020) Recommendation To give comprehensive recommendations about Severe Acute" exact="Respiratory" post="Syndrome Corona-virus 2 (COVID-19). Â A combination of anti-virals"/>
 <result pre="(2020) Recommendation To give comprehensive recommendations about Severe Acute Respiratory" exact="Syndrome" post="Corona-virus 2 (COVID-19). Â A combination of anti-virals Lopinavir/Ritonavir"/>
 <result pre="Review article This review summarized the knowledge about management of" exact="adult" post="acute respiratory infections and community-acquired viral pneumonia patients that"/>
 <result pre="article This review summarized the knowledge about management of adult" exact="acute" post="respiratory infections and community-acquired viral pneumonia patients that needed"/>
 <result pre="This review summarized the knowledge about management of adult acute" exact="respiratory" post="infections and community-acquired viral pneumonia patients that needed ICU."/>
 <result pre="review summarized the knowledge about management of adult acute respiratory" exact="infections" post="and community-acquired viral pneumonia patients that needed ICU. Â"/>
 <result pre="knowledge about management of adult acute respiratory infections and community-acquired" exact="viral pneumonia" post="patients that needed ICU. Â More research and studies"/>
 <result pre="about management of adult acute respiratory infections and community-acquired viral" exact="pneumonia" post="patients that needed ICU. Â More research and studies"/>
 <result pre="which drug can be a suitable option in COVID -19" exact="infection" post="There are no specific antiviral drugs available and no"/>
 <result pre="yet to be established. The mainstay of treatment still is" exact="symptomatic" post="support. Lim et al. (2020) Case Report This case"/>
 <result pre="are mild but can transmit the disease. Lopinavir/Ritonavir combination reduced" exact="viral" post="load and improved symptoms, so this combination can be"/>
 <result pre="the fact that almost everyone is susceptible. Still, mostly the" exact="disease" post="is mild, especially in children and immunocompetent adults [6]."/>
 <result pre="managed. A patient may present with clinical features of the" exact="disease" post="depending upon the severity of the disease. The different"/>
 <result pre="2 Clinical features of patients with a varying degree of" exact="disease" post="Mild disease Severe diseaseÂ Critical diseaseÂ Dry Cough Fever"/>
 <result pre="features of patients with a varying degree of disease Mild" exact="disease" post="Severe diseaseÂ Critical diseaseÂ Dry Cough Fever Respiratory failure"/>
 <result pre="of patients with a varying degree of disease Mild disease" exact="Severe" post="diseaseÂ Critical diseaseÂ Dry Cough Fever Respiratory failure Fever"/>
 <result pre="of disease Mild disease Severe diseaseÂ Critical diseaseÂ Dry Cough" exact="Fever" post="Respiratory failure Fever Tachypnea Fever Sour throat Dyspnea Decreases"/>
 <result pre="disease Mild disease Severe diseaseÂ Critical diseaseÂ Dry Cough Fever" exact="Respiratory" post="failure Fever Tachypnea Fever Sour throat Dyspnea Decreases blood"/>
 <result pre="disease Severe diseaseÂ Critical diseaseÂ Dry Cough Fever Respiratory failure" exact="Fever" post="Tachypnea Fever Sour throat Dyspnea Decreases blood oxygen saturation"/>
 <result pre="diseaseÂ Critical diseaseÂ Dry Cough Fever Respiratory failure Fever Tachypnea" exact="Fever" post="Sour throat Dyspnea Decreases blood oxygen saturation With or"/>
 <result pre="oxygen saturation With or without nasal congestion Â Septic shock" exact="Generalized" post="body aches Â Multiple organ failure Headache Â Â"/>
 <result pre="without nasal congestion Â Septic shock Generalized body aches Â" exact="Multiple" post="organ failure Headache Â Â Malaise and fatigue Â"/>
 <result pre="Â Â Malaise and fatigue Â Â Patients with mild" exact="disease" post="presented with dry cough, fever, sore throat, with or"/>
 <result pre="were tachypnea and dyspnea. In critical cases, patients complained of" exact="respiratory" post="failure (severe dyspnea, respiratory distress &amp;gt;30/min, tachypnea and hypoxia),"/>
 <result pre="In critical cases, patients complained of respiratory failure (severe dyspnea," exact="respiratory" post="distress &amp;gt;30/min, tachypnea and hypoxia), fever, decreased blood oxygen"/>
 <result pre="percussion, and a decrease in tactile speech tremor [6]. The" exact="disease" post="causes not only respiratory symptoms but also gastrointestinal symptoms"/>
 <result pre="in tactile speech tremor [6]. The disease causes not only" exact="respiratory" post="symptoms but also gastrointestinal symptoms such as diarrhea [15]."/>
 <result pre="not only respiratory symptoms but also gastrointestinal symptoms such as" exact="diarrhea" post="[15]. Laboratory complete blood count tests may show normal"/>
 <result pre="symptoms but also gastrointestinal symptoms such as diarrhea [15]. Laboratory" exact="complete" post="blood count tests may show normal or reduced white"/>
 <result pre="or reduced lymphocyte count in the early stages of the" exact="disease" post="onset [6,15]. Patients also show elevated C-reactive protein levels"/>
 <result pre="protein levels [16]. Researchers from China studied the effect of" exact="infection" post="on pregnant women suffering from COVID-19 on the neonates."/>
 <result pre="The complications are mostly seen in patients with an underlying" exact="chronic" post="illness or are old. Complications included acute respiratory distress"/>
 <result pre="with an underlying chronic illness or are old. Complications included" exact="acute" post="respiratory distress syndrome (ARDS), RNAemia, acute cardiac injury, and"/>
 <result pre="an underlying chronic illness or are old. Complications included acute" exact="respiratory" post="distress syndrome (ARDS), RNAemia, acute cardiac injury, and secondary"/>
 <result pre="chronic illness or are old. Complications included acute respiratory distress" exact="syndrome" post="(ARDS), RNAemia, acute cardiac injury, and secondary infection. The"/>
 <result pre="are old. Complications included acute respiratory distress syndrome (ARDS), RNAemia," exact="acute" post="cardiac injury, and secondary infection. The patients with complications"/>
 <result pre="acute respiratory distress syndrome (ARDS), RNAemia, acute cardiac injury, and" exact="secondary" post="infection. The patients with complications were admitted to the"/>
 <result pre="care unit (ICU) [15-16]. These clinical features indicate that the" exact="absence of" post="these symptoms in an individual does not rule out"/>
 <result pre="data, patients had similar presenting features and progression of the" exact="disease" post="with some minor differences according to the individual immune"/>
 <result pre="cases were tactile speech tremor, GI symptoms, hemoptysis, ARDS, and" exact="septic shock" post="[2,6,15,17-18]. Pathological and Radiological Findings In COVID-19 Patients Radiological"/>
 <result pre="mostly distributed along the subpleural regions in both lungs. No" exact="pleural" post="effusion or lymphadenopathy was observed in subjects included in"/>
 <result pre="day, the patient had increased consolidation, and the patient showed" exact="diffuse" post="haziness in both lungs. Other findings were bat wing"/>
 <result pre="crazy paving pattern, and air-bronchogram sign. The lesions involved the" exact="peripheral" post="regions of both the lungs [17]. Another study conducted"/>
 <result pre="was 50 years. More than 50% of the patients had" exact="bilateral" post="multifocal lesions in their lungs distributed along the periphery."/>
 <result pre="bilateral multifocal lesions in their lungs distributed along the periphery." exact="Pneumonia" post="in these patients presented with ground-glass opacities in 72%,"/>
 <result pre="paving pattern in 12%, interlobular thickening in 56% and adjacent" exact="pleural" post="thickening in 56% of patients. Twenty-three percent of the"/>
 <result pre="study done by Xu X et al. Uncommon findings were" exact="pleural" post="effusion, thoracic lymphadenopathy, pulmonary emphysema, and pericardial effusion. CT"/>
 <result pre="X et al. Uncommon findings were pleural effusion, thoracic lymphadenopathy," exact="pulmonary emphysema," post="and pericardial effusion. CT scan of 52 patients was"/>
 <result pre="Uncommon findings were pleural effusion, thoracic lymphadenopathy, pulmonary emphysema, and" exact="pericardial effusion." post="CT scan of 52 patients was redone after six"/>
 <result pre="have any characteristic findings on a previous CT scan developed" exact="bilateral" post="ground-glass opacities [16]. Another study carried out by Albarello"/>
 <result pre="al. based on two cases showed somewhat uncommon findings. The" exact="chest" post="X-ray of the two patients showed interstitial involvement, lung"/>
 <result pre="X-ray of the two patients showed interstitial involvement, lung opacities," exact="pleural" post="effusion and calcification, hilar enlargement, and cardiac silhouette. Their"/>
 <result pre="ones like ground-glass opacities with consolidation. Some uncommon findings like" exact="pleural" post="effusion, calcifications, mediastinal lymphadenopathy, and pericardial effusions were also"/>
 <result pre="who developed ARDS and severe pneumonia. The study included a" exact="total" post="of 21 patients with confirmed COVID-19 diagnosis. The study"/>
 <result pre="diagnosis. The study showed there are four stages in the" exact="disease" post="progression based on CT findings. Early-stage (0-4 days after"/>
 <result pre="(0-4 days after the onset of initial symptoms) of the" exact="disease" post="showed unilateral or bilateral ground-glass opacities, mostly in the"/>
 <result pre="after the onset of initial symptoms) of the disease showed" exact="unilateral" post="or bilateral ground-glass opacities, mostly in the lower lobes"/>
 <result pre="onset of initial symptoms) of the disease showed unilateral or" exact="bilateral" post="ground-glass opacities, mostly in the lower lobes of lungs."/>
 <result pre="disease showed unilateral or bilateral ground-glass opacities, mostly in the" exact="lower" post="lobes of lungs. Progressive stage (5-8 days after the"/>
 <result pre="bilateral ground-glass opacities, mostly in the lower lobes of lungs." exact="Progressive" post="stage (5-8 days after the onset of initial symptoms)"/>
 <result pre="symptoms) consolidations became denser and more prevalent, and there were" exact="residual" post="parenchymal bands. Absorption Stage (14 or more days after"/>
 <result pre="the characteristic findings of COVID-19. In some patients, mediastinal lymphadenopathy," exact="pleural" post="effusion, pulmonary emphysema, and pericardial effusion are seen and"/>
 <result pre="findings of COVID-19. In some patients, mediastinal lymphadenopathy, pleural effusion," exact="pulmonary emphysema," post="and pericardial effusion are seen and are mostly in"/>
 <result pre="In some patients, mediastinal lymphadenopathy, pleural effusion, pulmonary emphysema, and" exact="pericardial effusion" post="are seen and are mostly in older patients and"/>
 <result pre="COVID-19 patients are also helpful in determining the severity of" exact="disease" post="and the stage of the disease. Also, in the"/>
 <result pre="of the disease. Also, in the areas where they have" exact="limited" post="testing services, CT scan findings can be used as"/>
 <result pre="the initial stages of the infection, ground-glass opacities are frequently" exact="bilateral" post="and present in the lower lobes and the periphery."/>
 <result pre="infection, ground-glass opacities are frequently bilateral and present in the" exact="lower" post="lobes and the periphery. They may then progress to"/>
 <result pre="was more marked in the outer regions of the lungs." exact="Mucinous" post="and hemorrhagic exudates were present in the bronchi. On"/>
 <result pre="hemorrhagic exudates were present in the bronchi. On histopathology, extensive" exact="pulmonary" post="interstitial fibrosis with hyaline degeneration was evident. There were"/>
 <result pre="exudates were present in the bronchi. On histopathology, extensive pulmonary" exact="interstitial fibrosis" post="with hyaline degeneration was evident. There were signs of"/>
 <result pre="vessels showed severe congestion, thickening of walls and occlusion or" exact="stenosis" post="of the blood vessel; lumen and microthrombi were present"/>
 <result pre="was marked. There was marked necrosis of bronchial walls. Mainly" exact="type 2" post="pneumocytes were affected, and various metaplastic changes of epithelium"/>
 <result pre="changes of epithelium were observed. Multinucleated giant cells and intracytoplasmic" exact="viral" post="inclusions were also observed [22]. Another study conducted by"/>
 <result pre="the biopsy samples taken from the deceased COVID-19 patient showed" exact="diffuse" post="alveolar damage bilaterally with cellular fibromyxoid exudates. There was"/>
 <result pre="having large nuclei, granular cytoplasm, and prominent nucleoli showing the" exact="viral" post="cytopathic change [18]. Another study conducted by Zhang H"/>
 <result pre="based on the biopsy findings of deceased COVID-19 patients showed" exact="diffuse" post="alveolar damage and type 2 pneumocyte hyperplasia. Fibrinous exudates"/>
 <result pre="findings of deceased COVID-19 patients showed diffuse alveolar damage and" exact="type 2" post="pneumocyte hyperplasia. Fibrinous exudates were seen in the alveoli,"/>
 <result pre="pneumocyte hyperplasia. Fibrinous exudates were seen in the alveoli, and" exact="interstitial fibrosis" post="was evident. Interstitial infiltration of inflammatory cells was also"/>
 <result pre="were seen in the alveoli, and interstitial fibrosis was evident." exact="Interstitial" post="infiltration of inflammatory cells was also observed [23]. Based"/>
 <result pre="bronchi. On the other hand, characteristic histopathological findings were severe" exact="pulmonary" post="interstitial fibrosis, hemorrhagic infarction. Small vessels were mainly affected,"/>
 <result pre="On the other hand, characteristic histopathological findings were severe pulmonary" exact="interstitial fibrosis," post="hemorrhagic infarction. Small vessels were mainly affected, and they"/>
 <result pre="they showed signs of congestion and were occluded by microthrombi." exact="Type 2" post="pneumocytes were the primary cells that affected their nuclei"/>
 <result pre="and were occluded by microthrombi. Type 2 pneumocytes were the" exact="primary" post="cells that affected their nuclei were atypically enlarged, and"/>
 <result pre="seen, and some studies also suggested the presence of intracytoplasmic" exact="viral" post="inclusions. Prevention and Treatmentof COVID-19 Several options are in"/>
 <result pre="proved to be effective in flattening the curve of COVID-19" exact="infection" post="and keeping the total cases within the healthcare systemâ€™s"/>
 <result pre="in flattening the curve of COVID-19 infection and keeping the" exact="total" post="cases within the healthcare systemâ€™s capabilities. It is proposed"/>
 <result pre="practice self-isolation, keep a check on their symptoms along with" exact="symptomatic" post="measures like antipyretic. Whereas in some regions where the"/>
 <result pre="of the patients do progress to severe form of the" exact="disease" post="or ARDS and multi-organ failure and then need ICU"/>
 <result pre="other supportive measures. Several factors cause the progression of the" exact="disease" post="from mild symptoms to severe and poor prognosis of"/>
 <result pre="symptoms. Other factors include co-morbidities and status of the existing" exact="disease" post="like increased d-dimer levels and high sepsis-related organ assessment"/>
 <result pre="One of the mainstays of treatment remains antivirals in any" exact="viral infection." post="Among antivirals are the neuraminidase inhibitors which worked in"/>
 <result pre="as effective as oseltamivir in patients with influenza and H1N1" exact="infections" post="[10]. However, these anti-virals are not that effective in"/>
 <result pre="that the combination of lopinavir and ritonavir significantly reduced the" exact="viral" post="load in a 54-year-old patient [12]. Another case series"/>
 <result pre="the results of this combination in four patients where severe" exact="pneumonia" post="and respiratory symptoms significantly improved, and one patient tested"/>
 <result pre="of this combination in four patients where severe pneumonia and" exact="respiratory" post="symptoms significantly improved, and one patient tested negative and"/>
 <result pre="could help manage and treat this virus [25]. Antibacterials: Superimposed" exact="bacterial infections" post="are common in patients with viral pneumonia, and use"/>
 <result pre="help manage and treat this virus [25]. Antibacterials: Superimposed bacterial" exact="infections" post="are common in patients with viral pneumonia, and use"/>
 <result pre="[25]. Antibacterials: Superimposed bacterial infections are common in patients with" exact="viral pneumonia," post="and use of antibacterial medications alongside as prophylaxis in"/>
 <result pre="of antibacterial medications alongside as prophylaxis in moderate to severe" exact="infections" post="or wherever there is suspected superimposed infection. It is,"/>
 <result pre="recommended to avoid a combination of broad-spectrum antibiotics or their" exact="blind" post="administration [6, 9]. The antibiotic treatment recommended for community-acquired"/>
 <result pre="pneumonia, like Azithromycin, fluoroquinolones can be administered to cover common" exact="bacterial" post="pathogens.Â Immune modulator drugs: Chloroquine and hydroxychloroquine, the immune"/>
 <result pre="drugs used as antimalarials, and as a DMARD in Rheumatoid" exact="Arthritis" post="and also in autoimmune diseases like Lupus were found"/>
 <result pre="and as a DMARD in Rheumatoid Arthritis and also in" exact="autoimmune diseases" post="like Lupus were found effective in SARS infection and"/>
 <result pre="DMARD in Rheumatoid Arthritis and also in autoimmune diseases like" exact="Lupus" post="were found effective in SARS infection and so were"/>
 <result pre="in autoimmune diseases like Lupus were found effective in SARS" exact="infection" post="and so were tried in COVID-19 patients as well."/>
 <result pre="and immune-modulating properties, which increase its effectiveness in stopping the" exact="viral" post="replication in vivo [13,26]. Chloroquine, however, is associated with"/>
 <result pre="significant improvement in symptoms and a decrease in viremia and" exact="viral" post="load in seven out of 10 patients without any"/>
 <result pre="are needed to assess its potential serious side-effects like transfusion-related" exact="acute" post="lung injury (TRALI). Supportive treatment: Supportive treatment like oxygen"/>
 <result pre="hypoxemia, Extracorporeal membrane oxygenation (ECMO) is used. Patients with severe" exact="respiratory" post="Distress may need ventilator support.Â Corticosteroids may be used"/>
 <result pre="are controversial as they may make patients more prone to" exact="infections" post="[9]. Limitations Most of the clinical trials are currently"/>
 <result pre="cough, shortness of breath, and myalgiaÂ whereas some mayÂ develop" exact="pneumonia" post="and ARDS. Frequently seen radiological and pathological findings are"/>
 <result pre="pneumonia and ARDS. Frequently seen radiological and pathological findings are" exact="bilateral" post="ground-glass opacities in peripheries of lungs, consolidations, crazy paving"/>
 <result pre="peripheries of lungs, consolidations, crazy paving pattern, air bronchogram sign," exact="diffuse" post="alveolar damage, fibrinous exudates in bronchi, formation of hyaline"/>
 <result pre="being researched.Â Currently, the focus is on the prevention of" exact="disease" post="by practicing social distancing until a vaccine is developed."/>
 <result pre="no competing interests exist. References References 1World Health Organization. Coronavirus" exact="disease" post="2019 (â€ŽCOVID- 19)â€Ž: situation report, 872020. World Health Organizationhttps://apps.who.int/iris/handle/10665/331785"/>
 <result pre="Publishing; LLCStatPearls2020https://www.ncbi.nlm.nih.gov/books/NBK554776/ 3Clinical course and risk factors for mortality of" exact="adult" post="inpatients with COVID-19 in Wuhan, China: a retrospective cohort"/>
 <result pre="the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected" exact="pneumonia" post="(standard version)Mil Med ResJinYHCaiLChengZSet al.47202032029004 7Correlation of chest CT"/>
 <result pre="(2019-nCoV) infected pneumonia (standard version)Mil Med ResJinYHCaiLChengZSet al.47202032029004 7Correlation of" exact="chest" post="CT and RT-PCR testing in coronavirus disease 2019 (COVID-19)"/>
 <result pre="al.47202032029004 7Correlation of chest CT and RT-PCR testing in coronavirus" exact="disease" post="2019 (COVID-19) in China: a report of 1014 casesRadiologyAiTYangZHouHet"/>
 <result pre="containing COVID-19J Clin InvesCasadevallAPirofskiLA154515481302020https://www.jci.org/articles/view/138003 9Diagnosis and clinical management of severe" exact="acute" post="respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation"/>
 <result pre="COVID-19J Clin InvesCasadevallAPirofskiLA154515481302020https://www.jci.org/articles/view/138003 9Diagnosis and clinical management of severe acute" exact="respiratory" post="syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of"/>
 <result pre="Clin InvesCasadevallAPirofskiLA154515481302020https://www.jci.org/articles/view/138003 9Diagnosis and clinical management of severe acute respiratory" exact="syndrome" post="Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking"/>
 <result pre="Microbes InfectLiT5825859202032172669 10Critical care management of adults with community-acquired severe" exact="respiratory" post="viral infection. Intensive Care MedArabiYMFowlerRHaydenFG315328462020 11Drug treatment options for"/>
 <result pre="InfectLiT5825859202032172669 10Critical care management of adults with community-acquired severe respiratory" exact="viral infection." post="Intensive Care MedArabiYMFowlerRHaydenFG315328462020 11Drug treatment options for the 2019-new"/>
 <result pre="of the Index Patient Who Caused Tertiary Transmission of COVID-19" exact="Infection" post="in Korea: the Application of Lopinavir/Ritonavir for the Treatment"/>
 <result pre="the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected" exact="Pneumonia" post="Monitored by Quantitative RT-PCRJ Korean Med SciLimJJeonSShinHYet al.7910352020 13Remdesivir"/>
 <result pre="recently emerged novel coronavirus (2019-nCoV) in vitroCell ResWangMCaoRZhangLet al.26927130202032020029 14Coronavirus" exact="Disease" post="2019 (COVIDâ€� 19): What we know?J Med VirolHeFDengYLiW17202031502247 15Clinical"/>
 <result pre="J Nucl Med Mol ImagingXuXYuCQuJet al.1275128047202032107577 172019 Novel Coronavirus (COVID-19)" exact="pneumonia" post="with hemoptysis as the initial symptom: CT and clinical"/>
 <result pre="clinical featuresKorean J RadiolShiFYuQHuangWTanC53754021202032174057 18Pathological findings of COVID-19 associated with" exact="acute" post="respiratory distress syndromeLancet Respir MedXuZShiLWangYet al.4204228202032085846 19Novel Coronavirus pneumonia"/>
 <result pre="featuresKorean J RadiolShiFYuQHuangWTanC53754021202032174057 18Pathological findings of COVID-19 associated with acute" exact="respiratory" post="distress syndromeLancet Respir MedXuZShiLWangYet al.4204228202032085846 19Novel Coronavirus pneumonia outbreak"/>
 <result pre="with acute respiratory distress syndromeLancet Respir MedXuZShiLWangYet al.4204228202032085846 19Novel Coronavirus" exact="pneumonia" post="outbreak in 2019: computed tomographic findings in two casesKorean"/>
 <result pre="findings in two casesKorean J RadiolLinXGongZXiaoZet al.36536821202032056397 202019-novel Coronavirus severe" exact="adult" post="respiratory distress syndrome in two cases in Italy: An"/>
 <result pre="in two casesKorean J RadiolLinXGongZXiaoZet al.36536821202032056397 202019-novel Coronavirus severe adult" exact="respiratory" post="distress syndrome in two cases in Italy: An uncommon"/>
 <result pre="casesKorean J RadiolLinXGongZXiaoZet al.36536821202032056397 202019-novel Coronavirus severe adult respiratory distress" exact="syndrome" post="in two cases in Italy: An uncommon radiological presentationInt"/>
 <result pre="Infect DisAlbarelloFPianuraEDi StefanoFet al.19219793202032112966 21Time course of lung changes on" exact="chest" post="CT during recovery from 2019 novel coronavirus (COVID-19) pneumoniaRadiologyPanFYeTSunPet"/>
 <result pre="pneumoniaRadiologyPanFYeTSunPet al.2003702020 22Clinical pathology of critical patient with novel coronavirus" exact="pneumonia" post="(COVID-19)Pathology &amp;amp; PathobiologyLuoWYuHGouJet al.2020https://www.preprints.org/manuscript/202002.0407/v1 23Prevalence of comorbidities in the"/>
 <result pre="and therapeutic procedure for four cases with 2019 novel coronavirus" exact="pneumonia" post="receiving combined Chinese and Western medicine treatmentBiosci TrendsWangZChenXLuYChenFZhangW646814202032037389 25Anti-HCV,"/>
 <result pre="phosphate has shown apparent efficacy in treatment of COVID-19 associated" exact="pneumonia" post="in clinical studiesBiosci TrendsGaoJTianZYangX727314202032074550 27Feasibility, safety, clinical, and laboratory"/>
 <result pre="effects of convalescent plasma therapy for patients with Middle East" exact="respiratory" post="syndrome coronavirus infection: a study protocolSpringerplusArabiYBalkhyHHajeerAHet al.70942015https://doi.org/10.1186/s4006426618098 28Treatment of"/>
 <result pre="of convalescent plasma therapy for patients with Middle East respiratory" exact="syndrome" post="coronavirus infection: a study protocolSpringerplusArabiYBalkhyHHajeerAHet al.70942015https://doi.org/10.1186/s4006426618098 28Treatment of 5"/>
</results>
